Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01859884 · ClinicalTrials.gov registry record · NA
Optimizing Kidney Transplant Informed Consent
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
NCT01859884: Completed NA study, sponsored by Northwestern University.
NCT01859884 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 288 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01859884, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate kidney transplant candidates' comprehension about increased risk donor kidneys necessary for informed consent. We have developed a web-based tool that educates and assesses candidates' comprehension (Inform Me), as a supplement to current informed consent processes. We will then compare the effectiveness of the current informed consent processes supplemented by Inform Me, with the current consent processes alone for kidney transplant.
Primary Outcome
Assess knowledge of increased risk donor kidneys
Interventions
- BEHAVIORAL Inform Me: web-based education tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-11 |
| Phase | NA |
What the finished NCT01859884 record still lists
NCT01859884 is an interventional study that assigns participants to a tested intervention. The registered 288 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Inform Me: web-based education tool is the first listed.
NCT01859884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01859884 about?
NCT01859884 is a clinical study titled "Optimizing Kidney Transplant Informed Consent". The objective of this study is to evaluate kidney transplant candidates' comprehension about increased risk donor kidneys necessary for informed consent. We have developed a web-based tool that educates and assesses candidates' comprehension (Inform Me), as a supplement to current informed consent p...
What is the current status of trial NCT01859884?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2013-10. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01859884?
The interventions under investigation include: Inform Me: web-based education tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT01859884?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01859884's enrollment target sits among peer trials
288 376th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
- NCT03741777 · 288 participants · NA
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
- NCT03937635 · 288 participants · Phase 3
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- NCT04621877 · 288 participants · NA
Lay-Delivered Behavioral Activation in Senior Centers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia